UCB Group Announces Plan to Acquire Solutia Businesses

February 2003
Industrial Paint & Powder;Feb2003, Vol. 79 Issue 2, p6
Trade Publication
Focuses on the acquisition of UCB Group by Solutia Inc. Financial context of the merger; Identification of Solutia businesses acquired by UCB; Launch of Surface Specialties business by UCB.


Related Articles

  • Ferro agrees to buy portion of Solutia.  // Plastics News;8/28/2000, Vol. 12 Issue 26, p11 

    Reports on Ferro Corp.'s agreement to buy Solutia Inc.'s polymer-modifiers business and related manufacturing facilities in New Jersey, Wales and Belgium. Annual sales of the acquired business.

  • Ferro to Buy Solutia's $140MM Polymer Modifiers Business Unit. Chang, Joseph // Chemical Market Reporter;06/26/2000, Vol. 257 Issue 26, p1 

    Reports that Ferro Corp. has signed a definitive agreement to acquire Solutia Inc.'s polymer modifiers business and related manufacturing facilities. Benefits of the agreement to Ferro; Assets included in the transaction; Views of Solutia on the deal.

  • Solutia Sells Resins, Additives And Adhesives. Lerner, Ivan; Chang, Joseph // Chemical Market Reporter;12/9/2002, Vol. 262 Issue 21, p1 

    Reports the agreement of Solutia Inc. to sell its resins, additives and adhesive businesses to UCB SA. Payment of substantial amount of debt; Amount of sales of Solutia; Inclusion of ten production sites in the deal.

  • Solutia Buys Cognis Phosphonates.  // Chemical Market Reporter;12/17/2001, Vol. 260 Issue 23, p3 

    Reports on the acquisition of Cognis Corporation's assets hydroxythylidene diphosphonic acid (HEDP) phosphonates by Solutia Incorporated. Industrial applications of HEDP; Uses of phosphonates; Plans for the HEDP customers of Cognis Corporation.

  • Innovia Films is the new name for ex-UCB business.  // Packaging Magazine;10/21/2004, Vol. 7 Issue 19, p14 

    The article reports that Innovia Films has been selected as the new name for the former films business of the UCB Group Ltd. The Euro320 million acquisition of the company by a consortium led by the former managing director of Hays Chemical Distribution, Dennis Matthewman and Candover Partners,...

  • COMPANY SPOTLIGHT - UCB.  // PharmaWatch: Biotechnology;Oct2006, Vol. 5 Issue 10, p21 

    The article presents information about Belgium-based chemical and pharmaceuticals group UCB Group Ltd. It is one of the largest pharmaceutical and chemical businesses in the country. It deals in three different industrial areas, namely pharmaceuticals, chemicals, and films. The company is...

  • UCB set to acquire Celltech for £1.5bn.  // PharmaWatch: Biotechnology;July 2004, Vol. 3 Issue 7, p18 

    Reports on the acquisition of Celltech Pharmaceuticals by UCB Group Ltd. Terms under the agreement; Benefits of the deal for both companies; Significance of the agreement for the pharmaceutical biotechnology industry.

  • Cytec Cuts Price for UCB Specialties.  // Chemical Market Reporter;2/14/2005, Vol. 267 Issue 7, p3 

    The article reports that Cytec Industries Inc. has reduced the price it will pay for UCB Group Ltd.'s Surface Specialties business. Cytec reduced the price by 5 percent because of the business's less-than-robust operating results. The noncash portion of the deal will be paid as previously agreed...

  • COMPANY SPOTLIGHT - UCB.  // PharmaWatch: Monthly Review;Oct2006, Vol. 5 Issue 10, p48 

    The article offers information on the Belgium-based pharmaceutical and chemical firm UCB Group Ltd. and its business plans. The company is planning to acquire Schwarz Pharma AG to boost its growth potential. It had acquired Great Britain based Celltech in the year 2004. The group focuses on...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics